Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02720302
Other study ID # 2015/141
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 2016
Est. completion date January 31, 2025

Study information

Verified date April 2024
Source Skane University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study is a public health project with the aim to treat overweight in children 9-11 years of age. After the first consultation the children are randomized to either continue the treatment at The Child Obesity Clinic, Child Department or to have the following 2-3 consultations on distance with Lync. Last visit for all children is on the Child Obesity Clinic after approximately 12 months. Follow up after at least 1 years will be performed.


Description:

This superiority study is a randomized trial with two independent treatment arms. The target for the enrollment is 50% in each of the two treatment groups. With 60 patients in each group, the study has 80% statistical power at 5% significance level to detect an average difference between the treatment groups in the intra-individual change in the BMI Z-score that is 0.51 x the standard deviation in the intra-individual change. Previous data from the investigators own group suggest that a reasonable estimate of the standard deviation in the intra-individual change in the BMI Z-score following intervention is 0.42. Thus, the study has 80% statistical power at 5% significance level to detect a difference in the intra-individual change in the BMI Z-score that is 0.51 x 0.42 = 0.21 on average. The study will with the present funding end its follow up in June 2017.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 94
Est. completion date January 31, 2025
Est. primary completion date December 20, 2017
Accepts healthy volunteers No
Gender All
Age group 9 Years to 12 Years
Eligibility Inclusion Criteria: - Children with overweight and not obese according to the definitions developed by Cole et al (4). It implies that we include children with the following age specific BMI Inclusion criteria - 9 years = AGE < 9 years, 6 months AND 19,0< BMI<23,0 - 9 years, 6 months => AGE < 10 Years AND 19,5 <BMI<23,5 - 10 years = AGE < 10 years, 6 months AND 20,0<BMI<24,0 - 10 years, 6 months=>AGE< 11 years AND 20,5<BMI<24,5 - 11 years = AGE < 11 years, 6 months AND 21,0<BMI<25,5 - 11 years, 6 months =>AGE<12 years AND 21,5<BMI<25,5 Exclusion Criteria: - Children and his/her parents not able to communicate in Swedish. - Children with monogenic obesity - Present less than 80% at school in the latest school year. - No foster care for the child or his/her brothers or sisters

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
SOFT
SOFT is based on systemic and solution-focused theories to change lifestyle and has shown positive effects on children with respect to the degree of obesity, physical fitness, self-esteem and family functioning.
TeleSOFT
The therapists communicate with the overweight child and his/her family by the SOFT method on distance by use of video.

Locations

Country Name City State
Sweden Barnmedicin Malmö Scania

Sponsors (2)

Lead Sponsor Collaborator
Skane University Hospital Lund University

Country where clinical trial is conducted

Sweden, 

References & Publications (4)

Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000 May 6;320(7244):1240-3. doi: 10.1136/bmj.320.7244.1240. — View Citation

Flodmark CE, Ohlsson T, Ryden O, Sveger T. Prevention of progression to severe obesity in a group of obese schoolchildren treated with family therapy. Pediatrics. 1993 May;91(5):880-4. — View Citation

Nowicka P, Flodmark CE. Family therapy as a model for treating childhood obesity: useful tools for clinicians. Clin Child Psychol Psychiatry. 2011 Jan;16(1):129-45. doi: 10.1177/1359104509355020. Epub 2010 Jul 22. — View Citation

Nowicka P, Pietrobelli A, Flodmark CE. Low-intensity family therapy intervention is useful in a clinical setting to treat obese and extremely obese children. Int J Pediatr Obes. 2007;2(4):211-7. doi: 10.1080/17477160701379810. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Body mass index standard deviation score (BMI Z-score) during treatment of overweight Body weight measured by Tanita device Change from Baseline in body weight at an average of 12 months
Secondary Change in fat percent measured by TANITA TANITA measures fat percent via bioimpedance Change from Baseline in fat percent at an average of 12 months
Secondary Change in fat distribution measured by abdominal height (F-indicator) F-indicator uses a laser beam to measure the abdominal height Change from Baseline in fat distribution at an average of 12 months
Secondary Change in fat distribution measured by waist circumference Measured using a measurement tape Change from Baseline in waist circumference at an average of 12 months
Secondary Change in KIDSCREEN-index Use a validated questionnaire Change from Baseline in Kidscreen index at an average of 12 months
Secondary Change in physical activity measured by Moves application to smartphone Measured through an app on a smart phone. Change from Baseline in physical activity at an average of 2, 4, 6, 8, 12 months
Secondary Change child's metabolic health (Blood pressure) Standardized laboratory tests will be performed Change from Baseline in metabolic health at an average of 12 months
Secondary Change child's metabolic health (LDL-cholesterol) Standardized laboratory tests will be performed Change from Baseline in metabolic health at an average of 12 months
Secondary Change child's metabolic health (HDL-cholesterol) Standardized laboratory tests will be performed Change from Baseline in metabolic health at an average of 12 months
Secondary Change child's metabolic health (triglycerides) Standardized laboratory tests will be performed Change from Baseline in metabolic health at an average of 12 months
Secondary Change child's metabolic health (HbA1c) Standardized laboratory tests will be performed Change from Baseline in metabolic health at an average of 12 months
Secondary Change child's metabolic health (F-blood glucose) Standardized laboratory tests will be performed Change from Baseline in metabolic health at an average of 12 months
Secondary Change child's metabolic health (f-insulin) Standardized laboratory tests will be performed Change from Baseline in metabolic health at an average of 12 months
Secondary Change child's metabolic health (ccK-18) Standardized laboratory tests will be performed Change from Baseline in metabolic health at an average of 12 months
Secondary Change child's metabolic health (ALAT) Standardized laboratory tests will be performed Change from Baseline in metabolic health at an average of 12 months
Secondary Change in dietary habits Normal procedure at The Child Obesity Unit using a questionnaire Change from Baseline in dietary habits at an average of 12 months
Secondary Change in Outcome Rating Scale and Session Rating Scale Measured psychological Health in general by four questions combined to a general score on a Visual analogue scale Change from Baseline in Outcome Rating Scale at an average of 2, 4, 6, 8, 12 months
Secondary Change in Session Rating Scale Measured assessment of the consultation by visual analogue scale Change from Baseline in Session Rating scale at an average of 2, 4, 6, 8, 12 months
See also
  Status Clinical Trial Phase
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Terminated NCT03299881 - Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss N/A
Completed NCT02805478 - Fat-Associated Cardiovascular Organ Dysfunction
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Completed NCT03759743 - Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject N/A
Completed NCT03610958 - Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss. N/A
Completed NCT03678766 - CHARGE: Controlling Hunger and ReGulating Eating N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT05376865 - Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers N/A
Completed NCT03625427 - Effect of Palmitoleic Acid on C-reactive Protein N/A
Active, not recruiting NCT03435445 - Online Platform for Healthy Weight Loss (POEmaS) N/A
Enrolling by invitation NCT05576116 - Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics N/A
Recruiting NCT05249465 - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention N/A
Active, not recruiting NCT06023095 - A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities Phase 1
Completed NCT03648892 - Brain Dopamine Function in Human Obesity Early Phase 1
Not yet recruiting NCT05751993 - Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions N/A
Recruiting NCT02887950 - Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause N/A
Completed NCT03097237 - High Fiber Rye Foods for Weight and Body Fat Reduction N/A
Terminated NCT02796144 - MEtformin and Lorcaserin for WeighT Loss in Schizophrenia Phase 4